1. Academic Validation
  2. Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes

Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes

  • P T. 2009 Mar;34(3):138-41.
Saloni Kapur 1 Mary Ellen Bonk
Affiliations

Affiliation

  • 1 Dr. Kapur is a Fellow, and Dr. Bonk is Manager of the Drug Information Group, both at the University HealthSystem Consortium in Oakbrook, Illinois. Drug Forecast is a regular column coordinated by Alan Caspi, PhD, PharmD, MBA, President of Caspi & Associates in New York, New York.
PMID: 19561849
Figures
Products